BBIXF (Bonus BioGroup) Total Equity: $-1.88 Mil (As of Dec. 2025)


BBIXF Bonus BioGroup Ltd BBIXF
30 GF Score
Price $0.11
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup Total Equity?

Bonus BioGroup BBIXF 30 Total Equity is $-1.88 Mil as of Dec. 2025. GuruFocus rates BBIXF with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Bonus BioGroup's total equity for the quarter that ended in Dec. 2025 was $-1.88 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bonus BioGroup Total Equity Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup Total Equity Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.00 18.70 9.72 2.31 -1.88

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.72 5.11 2.31 -0.56 -1.88
BBIXF
30GF Score
Bonus BioGroup Ltd BBIXF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bonus BioGroup's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5.121-6.999
=-1.88

Bonus BioGroup's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=5.121-6.999
=-1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-1.88 Mil mean?
Bonus BioGroup (BBIXF) has a Total Equity of $-1.88 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Bonus BioGroup and its competitors.
Is Bonus BioGroup's Total Equity too high?
Bonus BioGroup's current Total Equity is $-1.88 Mil. Overall, Bonus BioGroup has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's Total Equity compare to VRTX and REGN?
Bonus BioGroup's Total Equity of $-1.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bonus BioGroup and its competitors. Bonus BioGroup's current Total Equity is $-1.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (BBIXF) has a current Total Equity of $-1.88 Mil. The current Total Equity is $-1.88 Mil. Bonus BioGroup's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bonus BioGroup (BBIXF), the current Total Equity is $-1.88 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BONS:Israel
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
30GF Score

Get the complete analysis for BBIXF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price